How we support our Full members
-
- EUMCA News Flash – Regular updates on current topics/issues related to medicinal cannabis
- Proactive support for members on upcoming media and industry specific issues related to their business
- Quarterly Government affairs reports
- Access and input to the development of briefing papers and policy positions
- Invite to our EUMCA Annual Meeting and EUMCA Conference
- Feedback from meetings and discussions with all key stakeholders in the EU (national governments, regulatory agencies, payers, patient organisations and Scientific leaders)
Company visits
Our membership team will arrange a company visit for new and existing members with our Senior Leadership Team, who will tailor their visit to your specific requirements and discuss key priorities and focus of the EUMCA in relation to your business
Access to Expert Networks and Specialist Working Group meetings
- We use project working groups and expert networks to cover most industry hot topics. These groups are made up of member companies with special interest and expertise in these areas. This means that we can react quickly to any new issues as they arise. It is these expert networks which help us to draw up responses to consultations and respond quickly to industry opportunities and challenges
- The EUMCA runs the specialist groups meetings at venues agreed by those members attending. Events are a valuable networking opportunity, with time allocated at the start of each session for informal networking
- Examples of Networks and groups include: Research & Development, Legal/Compliance, Regulatory & Quality, Patient Access & Reimbursement, Medical Education and Business Development
Access to expertise
- Full members receive access to expertise, knowledge and resources within the EUMCA on key matters affecting the medicinal cannabis industry.
- Full members may be involved with external activities along with their EUMCA associates, such as meeting politicians, advisers, stakeholders, and patient organisations within Europe
- Full members can engage directly with the EUMCA team and other company members to feed back and help shape policy on a wide range of areas
Membership fees
The annual membership fees for Full members are as below. The annual turnover is defined by the relevant EU provisions (Recommendation 2003/361/EC).
| Annual Turnover (EUR) | Annual Membership Fee |
| less than 1 Million | 2,000 EUR |
| from 1 Million | 3,000 EUR |
| from 3 Million | 4,000 EUR |
| from 5 Million | 5,000 EUR |
| from 8 Million | 7,000 EUR |
| from 10 Million | 8,000 EUR |
| from 15 Million | 10,000 EUR |
| from 25 Million | 15,000 EUR |
| from 50 Million | 20,000 EUR |
| from 100 Million | 40,000 EUR |
Organisations/Associations/Chairman are not charged a membership fee
How to apply
- Before applying for EUMCA membership you should have read the Membership Policy and Code of Conduct
- To apply for Full membership, please complete and return the Application Form. All applications for membership of the EUMCA are approved by the EUMCA Executive Board
- Further details about the application process can be found in our Membership Prospectus and FAQ section
Please contact membership services for more details on +32 233 90 281 or email info@eumca.org
Our Mission
In order to improve the life and health outcomes of patients across Europe, the EUMCA facilitates the development of national government healthcare policies that advocate for the ethical prescription of pharmaceutical-grade medicinal cannabis, and advance patient access to treatments
+32 233 90 281
info@eumca.org
EUMCA, Brussels, Belgium
Website by
